Back to Search
Start Over
EP08.01-098 Evaluating Risk Factors for Pneumonitis in Stage III NSCLC Patients Receiving Durvalumab after Definitive Chemoradiation.
- Source :
- Journal of Thoracic Oncology; 2022 Supplement, Vol. 17 Issue 9, pS389-S389, 1p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 15560864
- Volume :
- 17
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159037916
- Full Text :
- https://doi.org/10.1016/j.jtho.2022.07.670